Forum Πρωτοβάθμιας Φροντίδας Υγείας
Γενικά => Χρήσιμες πληροφορίες => Κυκλοφορούντα φάρμακα και γενόσημα τους => Μήνυμα ξεκίνησε από: Argirios Argiriou στις 12 Δεκεμβρίου 2017, 22:22:18
-
December 11, 2017
First Humalog Copycat (Admelog) Approved by FDA
Miriam E. Tucker
The US Food and Drug Administration (FDA) has approved Admelog (Sanofi-Adventis US), the first copycat version of short-acting insulin lispro (Humalog, Eli Lilly) to treat individuals aged 3 years and older with type 1 diabetes and adults with type 2 diabetes.
The product is approved for use as an injection, via pump, or intravenously. It will be available both in vials and as a prefilled pen (Admelog SoloStar).
https://www.medscape.com/viewarticle/889893?src=soc_fb_171212_mscpedt_news_endo,endo_diabetes&faf=1 (https://www.medscape.com/viewarticle/889893?src=soc_fb_171212_mscpedt_news_endo,endo_diabetes&faf=1)